707
Views
13
CrossRef citations to date
0
Altmetric
Reviews

Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy

ORCID Icon, &

References

  • Aktepe, O. H., T. K. Şahin, G. Güner, Z. Arik, and Ş. Yalçin. 2021. Lycopene sensitizes the cervical cancer cells to cisplatin via targeting nuclear factor- kappa B (NF-κB) pathway. Turkish Journal of Medical Sciences 51 (1):368–74. doi: 10.3906/sag-2005-413.
  • Ali, B. H., A. Abdelrahman, Y. Al Suleimani, P. Manoj, H. Ali, A. Nemmar, and M. A. Za’abi. 2020. Effect of concomitant treatment of curcumin and melatonin on cisplatin-induced nephrotoxicity in rats. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 131:110761 doi: 10.1016/j.biopha.2020.110761.
  • al-Shabanah, O. A., O. A. Badary, M. N. Nagi, N. M. Al-Gharably, A. C. Al-Rikabi, and A. M. Al-Bekairi. 1998. Thymoquinone protects against doxorubicin-induced cardiotoxicity without compromising its antitumor activity. Journal of Experimental & Clinical Cancer Research 17 (2):193–8.
  • Ali, B. H., A. Abdelrahman, Y. Al Suleimani, P. Manoj, H. Ali, A. Nemmar, and M. Al Za’abi. 2020. Effect of concomitant treatment of curcumin and melatonin on cisplatin-induced nephrotoxicity in rats. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 131:110761 doi:10.1016/j.biopha.2020.110761. PMC: 33152924
  • Badary, O. A., A. B. Abdel-Naim, M. H. Abdel-Wahab, and F. M. Hamada. 2000. The influence of thymoquinone on doxorubicin-induced hyperlipidemic nephropathy in rats. Toxicology 143 (3):219–26. doi: 10.1016/S0300-483X(99)00179-1.
  • Badary, O. A., M. N. Nagi, O. A. Al-Shabanah, H. A. Al-Sawaf, M. O. Al-Sohaibani, and A. M. Al-Bekairi. 1997. Thymoquinone ameliorates the nephrotoxicity induced by cisplatin in rodents and potentiates its antitumor activity. Canadian Journal of Physiology and Pharmacology 75 (12):1356–61. doi: 10.1139/y97-169.
  • Banerjee, S., Y. Zhang, S. Ali, M. Bhuiyan, Z. Wang, P. J. Chiao, P. A. Philip, J. Abbruzzese, and F. H. Sarkar. 2005. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Research 65 (19):9064–72. doi:10.1158/0008-5472.CAN-05-1330. PMID:16204081
  • Banerjee, S., Y. Zhang, Z. Wang, M. Che, P. J. Chiao, J. L. Abbruzzese, and F. H. Sarkar. 2007. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. International Journal of Cancer 120 (4):906–17. doi:10.1002/ijc.22332. PMID:17131310
  • Banerjee, S., S. Padhye, A. Azmi, Z. Wang, P. A. Philip, O. Kucuk, F. H. Sarkar, and R. M. Mohammad. 2010. Review on molecular and therapeutic potential of thymoquinone in cancer. Nutrition and Cancer 62 (7):938–46. doi: 10.1080/01635581.2010.509832.
  • Baur, J. A., and D. A. Sinclair. 2006. Therapeutic potential of resveratrol: The in vivo evidence. Nature Reviews. Drug Discovery 5 (6):493–506. doi: 10.1038/nrd2060.
  • Bava, S. V., C. N. Sreekanth, A. K. T. Thulasidasan, N. P. Anto, V. T. Cheriyan, V. T. Puliyappadamba, S. G. Menon, S. D. Ravichandran, and R. J. Anto. 2011. Akt is upstream and MAPKs are downstream of NF-κB in paclitaxel-induced survival signaling events, which are down-regulated by curcumin contributing to their synergism. The International Journal of Biochemistry & Cell Biology 43 (3):331–41. doi:10.1016/j.biocel.2010.09.011. PMID:20883815
  • Bava, S. V., V. T. Puliyappadamba, A. Deepti, A. Nair, D. Karunagaran, and R. J. Anto. 2005. Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization. The Journal of Biological Chemistry 280 (8):6301–8. doi: 10.1074/jbc.M410647200.
  • Bayat Mokhtari, R., N. Baluch, T. S. Homayouni, E. Morgatskaya, S. Kumar, P. Kazemi, and H. Yeger. 2018. The role of Sulforaphane in cancer chemoprevention and health benefits: A mini-review. Journal of Cell Communication and Signaling 12 (1):91–101. doi: 10.1007/s12079-017-0401-y.
  • Bentires-Alj, M., V. Barbu, M. Fillet, A. Chariot, B. Relic, N. Jacobs, J. Gielen, M. P. Merville, and V. Bours. 2003. NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 22 (1):90–7. doi: 10.1038/sj.onc.1206056.
  • Bertram, J. S. 1999. Carotenoids and gene regulation. Nutrition Reviews 57 (6):182–91. doi: 10.1111/j.1753-4887.1999.tb06941.x.
  • Bhardwaj, A., G. Sethi, S. Vadhan-Raj, C. Bueso-Ramos, Y. Takada, U. Gaur, A. S. Nair, S. Shishodia, and B. B. Aggarwal. 2007. Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109 (6):2293–302. doi: 10.1182/blood-2006-02-003988.
  • Bharti, A. C., N. Donato, S. Singh, and B. B. Aggarwal. 2003. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101 (3):1053–62. doi: 10.1182/blood-2002-05-1320.
  • Boreddy, S. R., and S. K. Srivastava. 2013. Pancreatic cancer chemoprevention by phytochemicals. Cancer Letters 334 (1):86–94. doi: 10.1016/j.canlet.2012.10.020.
  • Casanova, F., J. Quarti, D. C. da Costa, C. A. Ramos, J. L. da Silva, and E. Fialho. 2012. Resveratrol chemosensitizes breast cancer cells to melphalan by cell cycle arrest. Journal of Cellular Biochemistry 113 (8):2586–96. doi: 10.1002/jcb.24134.
  • Chan, J. M., M. J. Stampfer, J. Ma, P. Gann, J. M. Gaziano, M. Pollak, and E. Giovannucci. 2002. Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. CancerSpectrum Knowledge Environment 94 (14):1099–106. doi: 10.1093/jnci/94.14.1099.
  • Chehl, N., G. Chipitsyna, Q. Gong, C. J. Yeo, and H. A. Arafat. 2009. Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB : The Official Journal of the International Hepato Pancreato Biliary Association 11 (5):373–81. doi: 10.1111/j.1477-2574.2009.00059.x.
  • Chen, P., M.-D. Hu, X.-F. Deng, and B. Li. 2013. Genistein reinforces the inhibitory effect of Cisplatin on liver cancer recurrence and metastasis after curative hepatectomy. Asian Pacific Journal of Cancer Prevention : APJCP 14 (2):759–64. doi:10.7314/apjcp.2013.14.2.759. PMID:23621233
  • Chen, L., H. Deng, H. Cui, J. Fang, Z. Zuo, J. Deng, Y. Li, X. Wang, and L. Zhao. 2018. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9 (6):7204–18. doi: 10.18632/oncotarget.23208.
  • Chen, T. C., W. Wang, E. B. Golden, S. Thomas, W. Sivakumar, F. M. Hofman, S. G. Louie, and A. H. Schönthal. 2011. Green tea epigallocatechin gallate enhances therapeutic efficacy of temozolomide in orthotopic mouse glioblastoma models. Cancer Letters 302 (2):100–8. doi: 10.1016/j.canlet.2010.11.008.
  • Choudhari, A. S., P. C. Mandave, M. Deshpande, P. Ranjekar, and O. Prakash. 2019. Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice. Frontiers in Pharmacology 10 (:1614 doi: 10.3389/fphar.2019.01614.
  • Colin, D., A. Gimazane, G. Lizard, J.-C. Izard, E. Solary, N. Latruffe, and D. Delmas. 2009. Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells. International Journal of Cancer 124 (12):2780–8. doi:10.1002/ijc.24264. PMID:19334045
  • Dai, N., R. Ye, Q. He, P. Guo, H. Chen, and Q. Zhang. 2018. Capsaicin and sorafenib combination treatment exerts synergistic anti‑hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling. Oncol Rep 40 (6):3235–48. doi: 10.3892/or.2018.6754.
  • Daker, M., M. Ahmad, and A. S. Khoo. 2012. Quercetin-induced inhibition and synergistic activity with cisplatin - a chemotherapeutic strategy for nasopharyngeal carcinoma cells. Cancer Cell International 12 (1):34 doi: 10.1186/1475-2867-12-34.
  • Dhandapani, K. M., V. B. Mahesh, and D. W. Brann. 2007. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. Journal of Neurochemistry 102 (2):522–38. doi: 10.1111/j.1471-4159.2007.04633.x.
  • Dhima, I., S. Zerikiotis, P. Lekkas, Y. V. Simos, M. Gkiouli, P. Vezyraki, E. Dounousi, V. Ragos, X. Giannakopoulos, D. Baltogiannis, et al. 2019. Curcumin acts as a chemosensitizer for leiomyosarcoma cells in vitro but fails to mediate antioxidant enzyme activity in cisplatin-induced experimental nephrotoxicity in rats. Integrative Cancer Therapies 18:1534735419872811 doi: 10.1177/1534735419872811.
  • Díaz-Chávez, J., M. A. Fonseca-Sánchez, E. Arechaga-Ocampo, A. Flores-Pérez, Y. Palacios-Rodríguez, G. Domínguez-Gómez, L. A. Marchat, L. Fuentes-Mera, G. Mendoza-Hernández, P. Gariglio, et al. 2013. Proteomic profiling reveals that resveratrol inhibits HSP27 expression and sensitizes breast cancer cells to doxorubicin therapy. PLoS One 8 (5):e64378 doi: 10.1371/journal.pone.0064378.
  • Dogukan, A., M. Tuzcu, C. A. Agca, H. Gencoglu, N. Sahin, M. Onderci, I. H. Ozercan, N. Ilhan, O. Kucuk, and K. Sahin. 2011. A tomato lycopene complex protects the kidney from cisplatin-induced injury via affecting oxidative stress as well as Bax, Bcl-2, and HSPs expression. Nutrition and Cancer 63 (3):427–34. doi: 10.1080/01635581.2011.535958.
  • Donald, G., K. Hertzer, and G. Eibl. 2012. Baicalein-an intriguing therapeutic phytochemical in pancreatic cancer. Current Drug Targets 13 (14):1772–6. doi: 10.2174/138945012804545470.
  • Dou, J., Z. Wang, L. Ma, B. Peng, K. Mao, C. Li, M. Su, C. Zhou, and G. Peng. 2018. Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence. Oncotarget 9 (28):20089–102. doi: 10.18632/oncotarget.24015.
  • Dutta, B., J. E. Park, I. T. Y. Qing, O. L. Kon, and S. K. Sze. 2018. Soy-derived phytochemical genistein modifies chromatome topology to restrict cancer cell proliferation. Proteomics 18 (16):e1700474 doi: 10.1002/pmic.201700474.
  • El-Rayes, B. F., S. Ali, I. F. Ali, P. A. Philip, J. Abbruzzese, and F. H. Sarkar. 2006. Potentiation of the Effect of Erlotinib by Genistein in Pancreatic Cancer: The Role of Akt and Nuclear Factor-κB. Cancer Research 66 (21):10553–9. doi:10.1158/0008-5472.CAN-06-2333.
  • Elmallah, M. I. Y., and O. Micheau. 2019. Epigenetic regulation of TRAIL signaling: Implication for cancer therapy. Cancers (Basel) 11 (6)doi: 10.3390/cancers11060850.
  • Farghaly, M. E., A. A. Khowailed, B. E. Aboulhoda, L. A. Rashed, S. S. Gaber, and H. Ashour. 2021. Thymoquinone potentiated the anticancer effect of cisplatin on hepatic tumorigenesis by modulating tissue oxidative stress and endoplasmic GRP78/CHOP signaling. Nutrition and Cancer :1–10. doi: 10.1080/01635581.2021.1879880.
  • Ferreira, A. L., D. M. Salvadori, M. C. Nascimento, N. S. Rocha, C. R. Correa, E. J. Pereira, L. S. Matsubara, B. B. Matsubara, and M. S. Ladeira. 2007. Tomato-oleoresin supplement prevents doxorubicin-induced cardiac myocyte oxidative DNA damage in rats. Mutation Research. 631 (1):26–35. doi: 10.1016/j.mrgentox.2007.04.003.
  • Friedman, J. R., H. E. Perry, K. C. Brown, Y. Gao, J. Lin, C. D. Stevenson, J. D. Hurley, N. A. Nolan, A. T. Akers, Y. C. Chen, et al. 2017. Capsaicin synergizes with camptothecin to induce increased apoptosis in human small cell lung cancers via the calpain pathway. Biochemical Pharmacology 129:54–66. doi: 10.1016/j.bcp.2017.01.004.
  • Fulda, S., and K. M. Debatin. 2004. Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol. Oncogene 23 (40):6702–11. doi: 10.1038/sj.onc.1207630.
  • Garg, A. K., T. A. Buchholz, and B. B. Aggarwal. 2005. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxidants & Redox Signaling 7 (11/12):1630–47. doi: 10.1089/ars.2005.7.1630.
  • Gatouillat, G.,. E. Balasse, D. Joseph-Pietras, H. Morjani, and C. Madoulet. 2010. Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma. Journal of Cellular Biochemistry 110 (4):893–902. doi: 10.1002/jcb.22601.
  • Gerl, R., and D. L. Vaux. 2005. Apoptosis in the development and treatment of cancer. Carcinogenesis 26 (2):263–70. doi: 10.1093/carcin/bgh283.
  • Ghosh, S., and M. S. Hayden. 2012. Celebrating 25 years of NF-κB research. Immunological Reviews 246 (1):5–13. doi: 10.1111/j.1600-065X.2012.01111.x.
  • Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annual Review of Immunology 16:225–60. doi: 10.1146/annurev.immunol.16.1.225.
  • Goel, A., and B. B. Aggarwal. 2010. Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutrition and Cancer 62 (7):919–30. doi: 10.1080/01635581.2010.509835.
  • Golden, E. B., P. Y. Lam, A. Kardosh, K. J. Gaffney, E. Cadenas, S. G. Louie, N. A. Petasis, T. C. Chen, and A. H. Schönthal. 2009. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood 113 (23):5927–37. doi: 10.1182/blood-2008-07-171389.
  • Gong, T. T., X. D. Liu, Z. P. Zhan, and Q. J. Wu. 2020. Sulforaphane enhances the cisplatin sensitivity through regulating DNA repair and accumulation of intracellular cisplatin in ovarian cancer cells. Experimental Cell Research 393 (2):112061 doi: 10.1016/j.yexcr.2020.112061.
  • Granados-Principal, S., J. L. Quiles, C. L. Ramirez-Tortosa, P. Sanchez-Rovira, and M. C. Ramirez-Tortosa. 2010. New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients. Food and Chemical Toxicology 48 (6):1425–38. doi: 10.1016/j.fct.2010.04.007.
  • Gupta, S., K. Hastak, F. Afaq, N. Ahmad, and H. Mukhtar. 2004. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene 23 (14):2507–22. doi: 10.1038/sj.onc.1207353.
  • Gupta, S. C., R. Kannappan, S. Reuter, J. H. Kim, and B. B. Aggarwal. 2011. Chemosensitization of tumors by resveratrol. Annals of the New York Academy of Sciences 1215:150–60. doi: 10.1111/j.1749-6632.2010.05852.x.
  • Gupta, S. C., J. H. Kim, S. Prasad, and B. B. Aggarwal. 2010. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Reviews 29 (3):405–34. doi: 10.1007/s10555-010-9235-2.
  • Gupta, S. C., A. B. Kunnumakkara, S. Aggarwal, and B. B. Aggarwal. 2018. Inflammation, a double-edge sword for cancer and other age-related diseases. Frontiers in Immunology 9:2160. doi: 10.3389/fimmu.2018.02160.
  • Gupta, S. C., B. Sung, J. H. Kim, S. Prasad, S. Li, and B. B. Aggarwal. 2013. Multitargeting by turmeric, the golden spice: From kitchen to clinic. Molecular Nutrition & Food Research 57 (9):1510–28. doi: 10.1002/mnfr.201100741.
  • Hadad, N., and R. Levy. 2012. The synergistic anti-inflammatory effects of lycopene, lutein, β-carotene, and carnosic acid combinations via redox-based inhibition of NF-κB signaling. Free Radical Biology & Medicine 53 (7):1381–91. doi: 10.1016/j.freeradbiomed.2012.07.078.
  • Han, S. Z., H. X. Liu, L. Q. Yang, L. D. Cui, and Y. Xu. 2017. Piperine (PP) enhanced mitomycin-C (MMC) therapy of human cervical cancer through suppressing Bcl-2 signaling pathway via inactivating STAT3/NF-κB. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 96:1403–10. doi: 10.1016/j.biopha.2017.11.022.
  • Harikumar, K. B., A. B. Kunnumakkara, G. Sethi, P. Diagaradjane, P. Anand, M. K. Pandey, J. Gelovani, S. Krishnan, S. Guha, and B. B. Aggarwal. 2010. Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. International Journal of Cancer 127 (2):68. doi: 10.1002/ijc.25041.
  • Hasima, N., and B. Ozpolat. 2014. Regulation of autophagy by polyphenolic compounds as a potential therapeutic strategy for cancer. Cell Death & Disease 5 (11):e1509 doi: 10.1038/cddis.2014.467.
  • Hazai, E., Z. Bikádi, F. Zsila, and S. F. Lockwood. 2006. Molecular modeling of the non-covalent binding of the dietary tomato carotenoids lycopene and lycophyll, and selected oxidative metabolites with 5-lipoxygenase. Bioorganic & Medicinal Chemistry 14 (20):6859–67. doi: 10.1016/j.bmc.2006.06.045.
  • He, S., G. Niu, J. Shang, Y. Deng, Z. Wan, C. Zhang, Z. You, and H. Shen. 2017. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway. Journal of Experimental & Clinical Cancer Research 36 (1):137 doi: 10.1186/s13046-017-0607-0.
  • Higgins, C. F. 2007. Multiple molecular mechanisms for multidrug resistance transporters. Nature 446 (7137):749–57. doi: 10.1038/nature05630.
  • Hou, C., L. Lu, Z. Liu, Y. Lian, and J. Xiao. 2021. Resveratrol reduces drug resistance of SCLC cells by suppressing the inflammatory microenvironment and the STAT3/VEGF pathway. FEBS Open Bio. doi: 10.1002/2211-5463.13230.
  • Hour, T. C., J. Chen, C. Y. Huang, J. Y. Guan, S. H. Lu, and Y. S. Pu. 2002. Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation. The Prostate 51 (3):211–8. doi: 10.1002/pros.10089.
  • Howells, L. M., A. Mitra, and M. M. Manson. 2007. Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines. International Journal of Cancer 121 (1):175–83. doi: 10.1002/ijc.22645.
  • Huh, H. C., S. Y. Lee, S. K. Lee, N. H. Park, and I. S. Han. 2011. Capsaicin induces apoptosis of cisplatin-resistant stomach cancer cells by causing degradation of cisplatin-inducible Aurora-A protein. Nutrition and Cancer 63 (7):1095–103. doi: 10.1080/01635581.2011.607548.
  • Ismail, N. I., Othman, I. F. Abas, H. Lajis, N., and R. Naidu. 2019. Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer. International Journal of Molecular Sciences 20 (10):2454. doi: 10.3390/ijms20102454.
  • Ivanov, V. N., M. A. Partridge, G. E. Johnson, S. X. Huang, H. Zhou, and T. K. Hei. 2008. Resveratrol sensitizes melanomas to TRAIL through modulation of antiapoptotic gene expression. Experimental Cell Research 314 (5):1163–76. doi: 10.1016/j.yexcr.2007.12.012.
  • Jain, A. K., K. Thanki, and S. Jain. 2013. Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: Implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity. Molecular Pharmaceutics 10 (9):3459–74. doi: 10.1021/mp400311j.
  • Jakubowicz-Gil, J.,. R. Paduch, T. Piersiak, K. Głowniak, A. Gawron, and M. Kandefer-Szerszeń. 2005. The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells. Biochemical Pharmacology 69 (9):1343–50. doi: 10.1016/j.bcp.2005.01.022.
  • Jewell, C., and N. M. O’Brien. 1999. Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat. British Journal of Nutrition 81 (3):235–42. doi: 10.1017/S0007114599000434.
  • Jiang, Z.-B., C. Xu, W. Wang, Y.-Z. Zhang, J.-M. Huang, Y.-J. Xie, Q.-Q. Wang, X.-X. Fan, X.-J. Yao, C. Xie, et al. 2021. Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells . Pharmacological Research 169:105656. doi: 10.1016/j.phrs.2021.105656.
  • Jo, Y., N. Choi, K. Kim, H.-J. Koo, J. Choi, and H. N. Kim. 2018. Chemoresistance of cancer cells: requirements of tumor microenvironment-mimicking in vitro models in anti-cancer drug development. Theranostics 8 (19):5259–75. doi: 10.7150/thno.29098.
  • Kamat, A. M., S. T. Tharakan, B. Sung, and B. B. Aggarwal. 2009. Curcumin Potentiates the Antitumor Effects of Bacillus Calmette-Guerin against Bladder Cancer through the Downregulation of NF-κB and Upregulation of TRAIL Receptors. Cancer Research 69 (23):8958–66. doi:10.1158/0008-5472.CAN-09-2045.
  • Karimi, G., M. Ramezani, and A. Abdi. 2005. Protective effects of lycopene and tomato extract against doxorubicin-induced cardiotoxicity. Phytotherapy Research 19 (10):912–4. doi: 10.1002/ptr.1746.
  • Karin, M. 1999. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation. The Journal of Biological Chemistry 274 (39):27339–42. doi: 10.1074/jbc.274.39.27339.
  • Kazemi, F., I. Karimi, and N. Yousofvand. 2021. Molecular docking study of lignanamides from Cannabis sativa against P-glycoprotein. In Silico Pharmacology 9 (1):6 doi: 10.1007/s40203-020-00066-7.
  • Khatoon, E., K. Banik, C. Harsha, B. L. Sailo, K. K. Thakur, A. D. Khwairakpam, R. Vikkurthi, T. B. Devi, S. C. Gupta, and A. B. Kunnumakkara. 2020. Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives. Seminars in Cancer Biology. 28:S1044-579x(20)30150-4. doi: 10.1016/j.semcancer.2020.06.014.
  • Kilic, U., K. Sahin, M. Tuzcu, N. Basak, C. Orhan, B. Elibol-Can, E. Kilic, F. Sahin, and O. Kucuk. 2014. Enhancement of Cisplatin sensitivity in human cervical cancer: epigallocatechin-3-gallate. Frontiers in Nutrition 1:28 doi: 10.3389/fnut.2014.00028.
  • Kim, J. H., S. C. Gupta, B. Park, V. R. Yadav, and B. B. Aggarwal. 2012. Turmeric (Curcuma longa) inhibits inflammatory nuclear factor (NF)-κB and NF-κB-regulated gene products and induces death receptors leading to suppressed proliferation, induced chemosensitization, and suppressed osteoclastogenesis. Molecular Nutrition & Food Research 56 (3):454–65. doi: 10.1002/mnfr.201100270.
  • Kim, M. K., K. Kim, J. Y. Han, J. M. Lim, and Y. S. Song. 2011. Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancer. Genes & Nutrition 6 (2):109–15. doi: 10.1007/s12263-011-0209-y.
  • Kim, S. Y., Y. J. Lee, E. H. Park, H. K. Yi, D. S. Jo, J. S. Kim, and P. H. Hwang. 2008. Capsaicin induced apoptosis and the enhanced anticancer effect of anticancer drugs in cancer cells. Korean Journal of Pediatrics 51 (3):307–14. doi: 10.3345/kjp.2008.51.3.307.
  • Ko, J. K., and K. K. Auyeung. 2013. Target-oriented mechanisms of novel herbal therapeutics in the chemotherapy of gastrointestinal cancer and inflammation. Current Pharmaceutical Design 19 (1):48–66. doi: 10.2174/13816128130109.
  • Kubota, T., Y. Uemura, M. Kobayashi, and H. Taguchi. 2003. Combined effects of resveratrol and paclitaxel on lung cancer cells. Anticancer Research 23 (5a):4039–46.
  • Kuhar, M., S. Imran, and N. Singh. 2007. Curcumin and quercetin combined with cisplatin to induce apoptosis in human laryngeal carcinoma Hep-2 cells through the mitochondrial pathway. Journal of Cancer Molecules 3 (4):121–128.
  • Kunnumakkara, A. B., P. Diagaradjane, P. Anand, K. B. Harikumar, H. B. Kuzhuvelil, A. Deorukhkar, J. Gelovani, S. Guha, S. Krishnan, and B. B. Aggarwal. 2009. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model. International Journal of Cancer 125 (9):2187–97. doi: 10.1002/ijc.24593.
  • Kunnumakkara, A. B., S. Guha, S. Krishnan, P. Diagaradjane, J. Gelovani, and B. B. Aggarwal. 2007. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Research 67 (8):3853–61. doi: 10.1158/0008-5472.Can-06-4257.
  • Kuo, M. T., Z. Liu, Y. Wei, Y. C. Lin-Lee, S. Tatebe, G. B. Mills, and H. Unate. 2002. Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling. Oncogene 21 (13):1945–54. doi: 10.1038/sj.onc.1205117.
  • Kwak, T. W., D. H. Kim, C.-W. Chung, H. M. Lee, C. H. Kim, Y.-I. Jeong, and D. H. Kang. 2013. Synergistic Anticancer Effects of Vorinostat and Epigallocatechin-3-Gallate against HuCC-T1 Human Cholangiocarcinoma Cells. Evidence-Based Complementary and Alternative Medicine : eCAM 2013:185158 doi:10.1155/2013/185158. PMC: 23864881
  • Kweon, S. H., J. H. Song, and T. S. Kim. 2010. Resveratrol-mediated reversal of doxorubicin resistance in acute myeloid leukemia cells via downregulation of MRP1 expression. Biochemical and Biophysical Research Communications 395 (1):104–10. doi: 10.1016/j.bbrc.2010.03.147.
  • La, X., L. Zhang, Z. Li, H. Li, and Y. Yang. 2019. (-)-Epigallocatechin Gallate (EGCG) Enhances the Sensitivity of Colorectal Cancer Cells to 5-FU by Inhibiting GRP78/NF-κB/miR-155-5p/MDR1 Pathway. Journal of Agricultural and Food Chemistry 67 (9):2510–8. doi: 10.1021/acs.jafc.8b06665.
  • Lan, C. Y., S. Y. Chen, C. W. Kuo, C. C. Lu, and G. C. Yen. 2019. Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells. Journal of Food and Drug Analysis 27 (4):887–96. doi: 10.1016/j.jfda.2019.07.001.
  • Langner, E., M. K. Lemieszek, and W. Rzeski. 2019. Lycopene, sulforaphane, quercetin, and curcumin applied together show improved antiproliferative potential in colon cancer cells in vitro. Journal of Food Biochemistry 43 (4):e12802 doi: 10.1111/jfbc.12802.
  • Lei, C.-S., Y.-C. Hou, M.-H. Pai, M.-T. Lin, and S.-L. Yeh. 2018. Effects of quercetin combined with anticancer drugs on metastasis-associated factors of gastric cancer cells: In vitro and in vivo studies. Journal of Nutritional Biochemistry 51:105–13. doi: 10.1016/j.jnutbio.2017.09.011.
  • Lev-Ari, S., A. Vexler, A. Starr, M. Ashkenazy-Voghera, J. Greif, D. Aderka, and R. Ben-Yosef. 2007. Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines. Cancer Investigation 25 (6):411–8. doi: 10.1080/07357900701359577.
  • Li, Y., F. Ahmed, S. Ali, P. A. Philip, O. Kucuk, and F. H. Sarkar. 2005. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Research 65 (15):6934–42. doi: 10.1158/0008-5472.Can-04-4604.
  • Li, Y., K. L. Ellis, S. Ali, B. F. El-Rayes, A. Nedeljkovic-Kurepa, O. Kucuk, P. A. Philip, and F. H. Sarkar. 2004. Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line. Pancreas 28 (4):e90–e95. 5. doi: 10.1097/00006676-200405000-00020.
  • Li, Y.-C., S.-M. He, Z.-X. He, M. Li, Y. Yang, J.-X. Pang, X. Zhang, K. Chow, Q. Zhou, W. Duan, et al. 2014. Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells. Cancer Letters 344 (2):239–59. doi: 10.1016/j.canlet.2013.11.001.
  • Lin, Y. H., L. Y. Zhu, Y. Q. Yang, Z. H. Zhang, Q. G. Chen, Y. P. Sun, J. J. Bi, X. M. Luo, Z. H. Ni, and X. B. Wang. 2021. Resveratrol inhibits MUC5AC expression by regulating SPDEF in lung cancer cells. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 89:153601.doi: 10.1016/j.phymed.2021.153601.
  • Liu, H., G. Lee, J. I. Lee, T. G. Ahn, and S. A. Kim. 2019. Effects of genistein on anti-tumor activity of cisplatin in human cervical cancer cell lines. Obstetrics and Gynecology Science 62 (5):322–8. doi: 10.5468/ogs.2019.62.5.322.
  • Liu, T., L. Zhang, D. Joo, and S. C. Sun. 2017. NF-κB signaling in inflammation. Signal Transduction and Targeted Therapy 2:17023. doi: 10.1038/sigtrans.2017.23.
  • Li, C., Z. Wang, Q. Wang, R. L. Ka Yan Ho, Y. Huang, M. S. S. Chow, C. W. Kei Lam, and Z. Zuo. 2018. Enhanced anti-tumor efficacy and mechanisms associated with docetaxel-piperine combination- in vitro and in vivo investigation using a taxane-resistant prostate cancer model. Oncotarget 9 (3):3338–52. doi: 10.18632/oncotarget.23235.
  • Li, S., Q. Zhao, B. Wang, S. Yuan, X. Wang, and K. Li. 2018. Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation. Phytotherapy Research 32 (8):1530–6. doi: 10.1002/ptr.6081.
  • Luo, T., J. Wang, Y. Yin, H. Hua, J. Jing, X. Sun, M. Li, Y. Zhang, and Y. Jiang. 2010. (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Breast Cancer Research 12 (1):R8 doi: 10.1186/bcr2473.
  • Ma, Y., J. Wang, L. Liu, H. Zhu, X. Chen, S. Pan, X. Sun, and H. Jiang. 2011. Genistein potentiates the effect of arsenic trioxide against human hepatocellular carcinoma: Role of Akt and nuclear factor-κB. Cancer Letters 301 (1):75–84. doi: 10.1016/j.canlet.2010.10.022.
  • Maliakel, D. M., T. V. Kagiya, and C. K. Nair. 2008. Prevention of cisplatin-induced nephrotoxicity by glucosides of ascorbic acid and alpha-tocopherol. Experimental and Toxicologic Pathology : official Journal of the Gesellschaft Fur Toxikologische Pathologie 60 (6):521–7. doi: 10.1016/j.etp.2008.04.015.
  • Malik, A., F. Afaq, S. Sarfaraz, V. M. Adhami, D. N. Syed, and H. Mukhtar. 2005. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 102 (41):14813–8. doi: 10.1073/pnas.0505870102.
  • Mitra, S., and R. Dash. 2018. Natural Products for the Management and Prevention of Breast Cancer. Evidence-Based Complementary and Alternative Medicine 2018:8324696 doi: 10.1155/2018/8324696.
  • Mohammad, I. S., W. He, and L. Yin. 2020. Insight on Multidrug Resistance and Nanomedicine Approaches to Overcome MDR. Critical Reviews in Therapeutic Drug Carrier Systems 37 (5):473–509. doi: 10.1615/CritRevTherDrugCarrierSyst.2020025052.
  • Mukhtar, H., and N. Ahmad. 2000. Tea polyphenols: Prevention of cancer and optimizing health. The American Journal of Clinical Nutrition 71 (6 Suppl):1698S702S; discussion 703S-4S. doi: 10.1093/ajcn/71.6.1698S.
  • Musial, C., K. Siedlecka-Kroplewska, Z. Kmiec, and M. Gorska-Ponikowska. 2021. Modulation of Autophagy in Cancer Cells by Dietary Polyphenols. Antioxidants (Basel) 10 (1). doi: 10.3390/antiox10010123.
  • Nessa, M. U., P. Beale, C. Chan, J. Q. Yu, and F. Huq. 2011. Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models. Anticancer Research 31 (11):3789–97.
  • Nihal, M., H. Ahsan, I. A. Siddiqui, H. Mukhtar, N. Ahmad, and G. S. Wood. 2009. (-)-Epigallocatechin-3-gallate (EGCG) sensitizes melanoma cells to interferon induced growth inhibition in a mouse model of human melanoma. Cell Cycle (Georgetown, Tex.) 8 (13):2057–63. doi: 10.4161/cc.8.13.8862.
  • Nishikawa, T., T. Nakajima, M. Moriguchi, M. Jo, S. Sekoguchi, M. Ishii, H. Takashima, T. Katagishi, H. Kimura, M. Minami, et al. 2006. A green tea polyphenol, epigalocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. Journal of Hepatology 44 (6):1074–82. doi: 10.1016/j.jhep.2005.11.045.
  • Nosrati, N.,. M. Bakovic, and G. Paliyath. 2017. Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds. International Journal of Molecular Sciences 18 (10):2050. doi: 10.3390/ijms18102050.
  • Oh, S. J., O. Kim, J. S. Lee, J. A. Kim, M. R. Kim, H. S. Choi, J. H. Shim, K. W. Kang, and Y. C. Kim. 2010. Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells. Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association 48 (11):3227–34. doi: 10.1016/j.fct.2010.08.028.
  • Padhye, S., S. Banerjee, A. Ahmad, R. Mohammad, and F. H. Sarkar. 2008. From here to eternity – the secret of Pharaohs: Therapeutic potential of black cumin seeds and beyond. Cancer Therapy 6 (b):495–510.
  • Pang, X., X. Zhang, Y. Jiang, Q. Su, Q. Li, and Z. Li. 2021. Autophagy: Mechanisms and Therapeutic Potential of Flavonoids in Cancer. Biomolecules 11 (2):135. doi: 10.3390/biom11020135.
  • Park, B. H., J. E. Lim, H. G. Jeon, S. I. Seo, H. M. Lee, H. Y. Choi, S. S. Jeon, and B. C. Jeong. 2016. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2. Oncotarget 7 (39):63870–86. doi: 10.18632/oncotarget.11563.
  • Patra, S., B. Pradhan, R. Nayak, C. Behera, K. C. Panda, S. Das, M. Jena, and S. K. Bhutia. 2021. Apoptosis and autophagy modulating dietary phytochemicals in cancer therapeutics: Current evidences and future perspectives. Phytotherapy Research 35 (8):4194–214. doi: 10.1002/ptr.7082.
  • Pianetti, S., S. Guo, K. T. Kavanagh, and G. E. Sonenshein. 2002. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Research 62 (3):652–5.
  • Pikarsky, E., R. M. Porat, I. Stein, R. Abramovitch, S. Amit, S. Kasem, E. Gutkovich-Pyest, S. Urieli-Shoval, E. Galun, and Y. Ben-Neriah. 2004. NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (7007):461–6. doi: 10.1038/nature02924.
  • Prasad, S., K. Phromnoi, V. R. Yadav, M. M. Chaturvedi, and B. B. Aggarwal. 2010. Targeting inflammatory pathways by flavonoids for prevention and treatment of cancer. Planta Medica 76 (11):1044–63. doi: 10.1055/s-0030-1250111.
  • Preet, R., P. Mohapatra, D. Das, S. R. Satapathy, T. Choudhuri, M. D. Wyatt, and C. N. Kundu. 2013. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC. Carcinogenesis 34 (2):277–86. doi: 10.1093/carcin/bgs351.
  • Psotová, J., S. Chlopcíková, P. Miketová, J. Hrbác, and V. Simánek. 2004. Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part III. Apigenin, baicalelin, kaempherol, luteolin and quercetin. Phytotherapy Research 18 (7):516–21. doi: 10.1002/ptr.1462.
  • Qiao, J., C. Gu, W. Shang, J. Du, W. Yin, M. Zhu, W. Wang, M. Han, and W. Lu. 2011. Effect of green tea on pharmacokinetics of 5-fluorouracil in rats and pharmacodynamics in human cell lines in vitro. Food and Chemical Toxicology 49 (6):1410–5. doi: 10.1016/j.fct.2011.03.033.
  • Qin, X. X., M. Y. Zhang, Y. Y. Han, J. H. Hao, C. J. Liu, and S. X. Fan. 2018. Beneficial Phytochemicals with Anti-Tumor Potential Revealed through Metabolic Profiling of New Red Pigmented Lettuces (Lactuca sativa L.). International Journal of Molecular Sciences 19 (4):1165. doi: 10.3390/ijms19041165.
  • Quan, F., C. Pan, Q. Ma, S. Zhang, and L. Yan. 2008. Reversal effect of resveratrol on multidrug resistance in KBv200 cell line. Biomedicine & Pharmacotherapy [Biomedecine & Pharmacotherapie] 62 (9):622–9. doi: 10.1016/j.biopha.2008.07.089.
  • Rao, A. V., N. Fleshner, and S. Agarwal. 1999. Serum and tissue lycopene and biomarkers of oxidation in prostate cancer patients: A case-control study. Nutrition and Cancer 33 (2):159–64. doi: 10.1207/s15327914nc330207.
  • Rezk, Y. A., S. S. Balulad, R. S. Keller, and J. A. Bennett. 2006. Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: Study in human gynecologic cancer cell lines and in rodent heart. American Journal of Obstetrics and Gynecology 194 (5):e23–e26. 6. doi: 10.1016/j.ajog.2005.11.030.
  • Rios, A. d O., L. M. G. Antunes, M. de, and L. P. Bianchi. 2009. Bixin and lycopene modulation of free radical generation induced by cisplatin–DNA interaction. Food Chemistry 113 (4):1113–8. doi: 10.1016/j.foodchem.2008.08.084.
  • Rizeq, B., I. Gupta, J. Ilesanmi, M. AlSafran, M. M. Rahman, and A. Ouhtit. 2020. The Power of Phytochemicals Combination in Cancer Chemoprevention. Journal of Cancer 11 (15):4521–33. doi: 10.7150/jca.34374.
  • Rong, Y., L. Huang, K. Yi, H. Chen, S. Liu, W. Zhang, C. Yuan, X. Song, and F. Wang. 2020. Co-administration of sulforaphane and doxorubicin attenuates breast cancer growth by preventing the accumulation of myeloid-derived suppressor cells. Cancer Letters 493:189–96. doi: 10.1016/j.canlet.2020.08.041.
  • Ryan, K. M., M. K. Ernst, N. R. Rice, and K. H. Vousden. 2000. Role of NF-kappaB in p53-mediated programmed cell death. Nature 404 (6780):892–7. doi: 10.1038/35009130.
  • Sahin, K., N. Sahin, and O. Kucuk. 2010. Lycopene and chemotherapy toxicity. Nutrition and Cancer 62 (7):988–95. doi: 10.1080/01635581.2010.509838.
  • Sahin, K., M. Tuzcu, N. Basak, B. Caglayan, U. Kilic, F. Sahin, and O. Kucuk. 2012. Sensitization of Cervical Cancer Cells to Cisplatin by Genistein: The Role of NFκB and Akt/mTOR Signaling Pathways. Journal of Oncology 2012:1–6. doi: 10.1155/2012/461562.
  • Sahin, K., M. Tuzcu, H. Gencoglu, A. Dogukan, M. Timurkan, N. Sahin, A. Aslan, and O. Kucuk. 2010. Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Life Sciences. 87 (7-8):240–5. doi: 10.1016/j.lfs.2010.06.014.
  • Sahin, K., M. Tuzcu, N. Sahin, S. Ali, and O. Kucuk. 2010. Nrf2/HO-1 signaling pathway may be the prime target for chemoprevention of cisplatin-induced nephrotoxicity by lycopene. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 48 (10):2670–4. doi: 10.1016/j.fct.2010.06.038.
  • Sahin, K., E. Yenice, B. Bilir, C. Orhan, M. Tuzcu, N. Sahin, I. H. Ozercan, N. Kabil, B. Ozpolat, and O. Kucuk. 2019. Genistein prevents development of spontaneous ovarian cancer and inhibits tumor growth in hen model. Cancer Prevention Research (Philadelphia, PA.) 12 (3):135–46. doi: 10.1158/1940-6207.Capr-17-0289.
  • Sahin, K., E. Yenice, M. Tuzcu, C. Orhan, C. Mizrak, I. H. Ozercan, N. Sahin, B. Yilmaz, B. Bilir, B. Ozpolat, et al. 2018. Lycopene protects against spontaneous ovarian cancer formation in laying hens. Journal of Cancer Prevention 23 (1):25–36. doi: 10.15430/JCP.2018.23.1.25.
  • Salehi, B., A. P. Mishra, M. Nigam, B. Sener, M. Kilic, M. Sharifi-Rad, P. V. T. Fokou, N. Martins, and J. Sharifi-Rad. 2018. Resveratrol: A double-edged sword in health benefits. Biomedicines 6 (3):91. doi: 10.3390/biomedicines6030091.
  • Scandlyn, M. J., E. C. Stuart, T. J. Somers-Edgar, A. R. Menzies, and R. J. Rosengren. 2008. A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate. British Journal of Cancer 99 (7):1056–63. doi:10.1038/sj.bjc.6604634.
  • Schirrmacher, V. 2019. From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review). International Journal of Oncology 54 (2):407–19. doi: 10.3892/ijo.2018.4661.
  • Sendão, M. C., E. B. Behling, R. A. dos Santos, L. M. Antunes, M. de, and L. Pires Bianchi. 2006. Comparative effects of acute and subacute lycopene administration on chromosomal aberrations induced by cisplatin in male rats. Food and Chemical Toxicology. 44 (8):1334–9. doi: 10.1016/j.fct.2006.02.010.
  • Shankar, S., S. Ganapathy, Q. Chen, and R. K. Srivastava. 2008. Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis. Molecular Cancer 7:16 doi:10.1186/1476-4598-7-16. PMC: 18226269
  • Shen, M., T. H. Chan, and Q. P. Dou. 2012. Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization. Anti-Cancer Agents in Medicinal Chemistry 12 (8):891–901. doi: 10.2174/187152012802649978.
  • Shimeda, Y., Y. Hirotani, Y. Akimoto, K. Shindou, Y. Ijiri, T. Nishihori, and K. Tanaka. 2005. Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biological and Pharmaceutical Bulletin. 28 (9):1635–8. doi: 10.1248/bpb.28.1635.
  • Singh, S. K., T. Apata, J. B. Gordetsky, and R. Singh. 2019. Docetaxel combined with thymoquinone induces apoptosis in prostate cancer cells via inhibition of the PI3K/AKT signaling pathway. Cancers (Basel) 11 (9). doi: 10.3390/cancers11091390.
  • Solomon, L. A., S. Ali, S. Banerjee, A. R. Munkarah, R. T. Morris, and F. H. Sarkar. 2008. Sensitization of ovarian cancer cells to cisplatin by genistein: The role of NF-kappaB. Journal of Ovarian Research 1 (1):9 doi: 10.1186/1757-2215-1-9.
  • Stearns, M. E., M. D. Amatangelo, D. Varma, C. Sell, and S. M. Goodyear. 2010. Combination therapy with epigallocatechin-3-gallate and doxorubicin in human prostate tumor modeling studies: Inhibition of metastatic tumor growth in severe combined immunodeficiency mice. Am J Pathol 177 (6):3169–79. doi: 10.2353/ajpath.2010.100330.
  • Sun, C. Y., Q. Y. Zhang, G. J. Zheng, and B. Feng. 2019. Phytochemicals: Current strategy to sensitize cancer cells to cisplatin. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 110:518–27. doi: 10.1016/j.biopha.2018.12.010.
  • Teiten, M. H., S. Eifes, M. Dicato, and M. Diederich. 2010. Curcumin-the paradigm of a multi-target natural compound with applications in cancer prevention and treatment. Toxins 2 (1):128–62. doi: 10.3390/toxins2010128.
  • Ting, C. Y., H. E. Wang, C. C. Yu, H. C. Liu, Y. C. Liu, and I. T. Chiang. 2015. Curcumin Triggers DNA damage and inhibits expression of DNA repair proteins in human lung cancer cells. Anticancer Research 35 (7):3867–73.
  • Ulu, R., A. Dogukan, M. Tuzcu, H. Gencoglu, M. Ulas, N. Ilhan, I. Muqbil, R. M. Mohammad, O. Kucuk, and K. Sahin. 2012. Regulation of renal organic anion and cation transporters by thymoquinone in cisplatin induced kidney injury. Food and Chemical Toxicology : An International Journal Published for the British Industrial Biological Research Association 50 (5):1675–9. doi: 10.1016/j.fct.2012.02.082.
  • Varoni, E. M., A. F. Lo Faro, J. Sharifi-Rad, and M. Iriti. 2016. Anticancer molecular mechanisms of resveratrol. Frontiers in Nutrition 3:8 doi: 10.3389/fnut.2016.00008.
  • Venkatraman, M., R. J. Anto, A. Nair, M. Varghese, and D. Karunagaran. 2005. Biological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosis. Mol Carcinog 44 (1):51–9. doi: 10.1002/mc.20116.
  • Vinod, B. S., J. Antony, H. H. Nair, V. T. Puliyappadamba, M. Saikia, S. S. Narayanan, A. Bevin, and R. J. Anto. 2013. Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil. Cell Death & Disease 4 (2):e505. doi: 10.1038/cddis.2013.26.
  • Vinod, B. S., T. T. Maliekal, and R. J. Anto. 2013. Phytochemicals as chemosensitizers: From molecular mechanism to clinical significance. Antioxid Redox Signal 18 (11):1307–48. doi: 10.1089/ars.2012.4573.
  • Wang, C. Y., J. C. Cusack, Jr., R. Liu, and A. S. Baldwin. Jr. 1999. Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nature Medicine 5 (4):412–7. doi: 10.1038/7410.
  • Wang, C. Y., M. W. Mayo, and A. S. Baldwin. Jr. 1996. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB. Science (New York, N.Y.) 274 (5288):784–7. doi: 10.1126/science.274.5288.784.
  • Wu, H., Y. Xin, Y. Xiao, and J. Zhao. 2012. Low-dose docetaxel combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts. Cancer Biotherapy & Radiopharmaceuticals 27 (3):204–9. doi: 10.1089/cbr.2011.1103.
  • Wu, H., Y. Xin, C. Xu, and Y. Xiao. 2012. Capecitabine combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts. Experimental and Therapeutic Medicine 3 (4):650–4. doi: 10.3892/etm.2012.448.
  • Wu, B., Q. Zhang, W. Shen, and J. Zhu. 2008. Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line. Molecular and Cellular Biochemistry 313 (1-2):125–32. doi: 10.1007/s11010-008-9749-x.
  • Xia, Y., S. Shen, and I. M. Verma. 2014. NF-κB, an active player in human cancers. Cancer Immunology Research 2 (9):823–30. doi: 10.1158/2326-6066.CIR-14-0112.
  • Xue, D., S. T. Pan, X. Zhou, F. Ye, Q. Zhou, F. Shi, F. He, H. Yu, and J. Qiu. 2020. Plumbagin enhances the anticancer efficacy of cisplatin by increasing intracellular ros in human tongue squamous cell carcinoma. Oxidative Medicine and Cellular Longevity 2020:5649174 doi: 10.1155/2020/5649174.
  • Yang, M. D., Y. Sun, W. J. Zhou, X. Z. Xie, Q. M. Zhou, Y. Y. Lu, and S. B. Su. 2021. Resveratrol enhances inhibition effects of cisplatin on cell migration and invasion and tumor growth in breast cancer MDA-MB-231 cell models in vivo and in vitro. Molecules 26 (8)2204. doi: 10.3390/molecules2608:.
  • Yi, X., L. Lou, J. Wang, J. Xiong, and S. Zhou. 2021. Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p/FBXW7/c-Myc pathway. Cancer Chemother Pharmacol 87 (5):647–56. doi: 10.1007/s00280-021-04238-w.
  • Zhang, L. X., R. V. Cooney, and J. S. Bertram. 1991. Carotenoids enhance gap junctional communication and inhibit lipid peroxidation in C3H/10T1/2 cells: Relationship to their cancer chemopreventive action. Carcinogenesis 12 (11):2109–14. doi: 10.1093/carcin/12.11.2109.
  • Zhang, B., Z. L. Shi, B. Liu, X. B. Yan, J. Feng, and H. M. Tao. 2010. Enhanced anticancer effect of gemcitabine by genistein in osteosarcoma: The role of Akt and nuclear factor-kappaB. Anti-Cancer Drugs 21 (3):288–96. doi: 10.1097/CAD.0b013e328334da17.
  • Zhang, S., Y. Wang, Z. Chen, S. Kim, S. Iqbal, A. Chi, C. Ritenour, Y. A. Wang, O. Kucuk, and D. Wu. 2013. Genistein enhances the efficacy of cabazitaxel chemotherapy in metastatic castration-resistant prostate cancer cells. The Prostate 73 (15):1681–9. doi: 10.1002/pros.22705.
  • Zhang, J., Y. Zhang, W. Shen, R. Fu, Z. Ding, Y. Zhen, and Y. Wan. 2019. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer. Biomedicine & Pharmacotherapy. 117:109058. doi: 10.1016/j.biopha.2019.109058.
  • Zhou, C., W. Han, P. Zhang, M. Cai, D. Wei, and C. Zhang. 2008. Lycopene from tomatoes partially alleviates the bleomycin-induced experimental pulmonary fibrosis in rats. Nutrition Research. 28 (2):122–30. doi: 10.1016/j.nutres.2007.12.008.
  • Zhu, H., H. Luo, W. Zhang, Z. Shen, X. Hu, and X. Zhu. 2016. Molecular mechanisms of cisplatin resistance in cervical cancer. Drug Design, Development and Therapy 10:1885–95. doi: 10.2147/dddt.S106412.
  • Zubair, H., S. Azim, A. Ahmad, M. A. Khan, G. K. Patel, S. Singh, and A. P. Singh. 2017. Cancer chemoprevention by phytochemicals: Nature’s healing touch. Molecules 22 (3):395. doi: 10.3390/molecules22030395.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.